The Board of Russian poultry Union discussed the prospects of veterinary medicines import substitution

During the event, such issues as epizootic situation of poultry flu and providing the industry with veterinary drugs, breeding products, feed additives in the context of restrictions and sanctions were considered.  

Alexander Velichko, Head of the Department for Government Relations of the VIC Group, noted that the Russian market of veterinary drugs currently is estimated at $ 40 billion and occupies only 3% of the global market, but at the same time Russia is rating among the TOP 5 meat and poultry producers in the world. According to experts, by 2030, the volume of the veterinary pharmaceuticals market in the Russian Federation may grow to $ 60 billion.

The speaker cited data on the 25 largest veterinary companies in the world, with only one company from the Russian Federation among them – the VIC Group, which ranks 21st in terms of capitalization and 25th among veterinary companies in the world in terms of revenue.

Moreover, Alexander Velichko spoke about the future of import substitution, noting that with the support of raw materials supplies from Asian countries, domestic manufacturers have the opportunity to promptly and fully satisfy the market needs for chemical and pharmaceutical products. In the development of coccidiostatics, where almost 90% of raw materials are produced in the EU and the USA, it is possible to replace the supplier with the partners from Asia.

The representative of the VIC Group noted that stocks of finished domestic and imported production are available in Russia now, and products and raw materials are expected to be delivered via modified logistics flows through Mongolia, Kazakhstan and Russia. So, there is no need to be afraid of interruptions in the supply of veterinary drugs.